EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
EV-101:恩福妥单药治疗Nectin-4阳性实体瘤(包括转移性尿路上皮癌)患者的I期研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.19.02044
Rosenberg, Jonathan; Sridhar, Srikala S; Zhang, Jingsong; Smith, David; Ruether, Dean; Flaig, Thomas W; Baranda, Joaquina; Lang, Joshua; Plimack, Elizabeth R; Sangha, Randeep; Heath, Elisabeth I; Merchan, Jamie; Quinn, David I; Srinivas, Sandy; Milowsky, Matthew; Wu, Chunzhang; Gartner, Elaina M; Zuo, Peiying; Melhem-Bertrandt, Amal; Petrylak, Daniel P